Status:

UNKNOWN

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers

Lead Sponsor:

KeraCure

Conditions:

Foot Ulcer

Diabetes

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The objective of this study is to determine the safety and effectiveness of a device (the KC-002 interactive wound dressing) in the promotion of healing in diabetic foot ulcers as compared with a conv...

Eligibility Criteria

Inclusion

  • Participants included in the study must:
  • Have Type 1 or Type 2 diabetes mellitus
  • Have a diabetic foot ulcer on the bottom of the foot or heal which has been present for three (3) weeks but less than two (2) years and is sufficient size to qualify for the study
  • Be able to visit the study doctor regularly for 24 weeks

Exclusion

  • Participants may not be included if:
  • The diabetic foot ulcer is infected
  • They have poor circulation in their study foot
  • Cannot or will not wear a special boot to take pressure off the study ulcer
  • They have certain other diseases or laboratory values which are not within a specified range

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2009

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT00330265

Start Date

January 1 2006

End Date

September 1 2009

Last Update

August 26 2008

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Institute for Advanced Wound Care at Baptist Medical Center South

Montgomery, Alabama, United States, 36111

2

HOPE Research Institute

Phoenix, Arizona, United States, 85050

3

Southern Arizona VA Health Care System

Tucson, Arizona, United States, 85723

4

Roy Kroeker, DPM

Fresno, California, United States, 93710